Previous 10 | Next 10 |
Image source: The Motley Fool. Stevanato Group S.p.A. (NYSE: STVN) Q4 2021 Earnings Call Mar 08, 2022 , 8:30 a.m. ET Lisa Miles Continue reading For further details see: Stevanato Group S.p.A. (STVN) Q4 2021 Earnings Call Transcript
Stevanato Group S.p.A. (STVN) Q4 2021 Results Earnings Conference Call March 8, 2022, 08:30 AM ET Company Participants Lisa Miles - Head of Investor Relations Franco Stevanato - Executive Chairman Franco Moro - Chief Executive Officer and Chief Operating Officer Marco Dal Lago - Chief Financi...
The following slide deck was published by Stevanato Group S.p.A. in conjunction with their 2021 Q4 earnings call. For further details see: Stevanato Group S.p.A. 2021 Q4 - Results - Earnings Call Presentation
Stevanato Group press release (NYSE:STVN): Q4 GAAP EPS of €0.17. Revenue of €232.6M (+12.5% Y/Y). The company established FY2022 guidance and expects revenue in the range of €935M to €945M, adjusted diluted earnings per share between €0.49 to ...
- Establishes Full Year 2022 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the f...
Stevanato (NYSE:STVN) said its unit OMPI of America signed an agreement to support the Biomedical Advanced Research and Development Authority (BARDA), pursuant to which BARDA will provide up to ~$95M to STVN. STVN will expand its planned manufacturing capacity in Fishers, Indiana, for both st...
Company to receive $95 million to expand vial production in the United States Stevanato Group (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that i...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will issue financial results for the fourth quarter and full year of fi...
The appointment bolsters company’s commitment to growth in the region Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the appointment of R...
Alina ® pen injector platform is now available for several new therapeutic areas Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has signed an extension...
News, Short Squeeze, Breakout and More Instantly...
Stevanato Group S.p.A. Company Name:
STVN Stock Symbol:
NYSE Market:
Stevanato Group S.p.A. Website:
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that it will issue financial results for the second quarter of 2024 on Tuesday, August 6, 2...
2024-07-04 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 21:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...